Skip to main content

This job has expired

You will need to login before you can apply for a job.

Process Engineer, LNP Process Sciences

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Sep 17, 2020

View more

Discipline
Engineering, Process Engineer, Manufacturing & Production
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Genetown

Job Details

Our mission:

Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases.

Summary:

Intellia is seeking a highly skilled and motivated Process Engineer/Associate Scientist to join our LNP Process Sciences team. The successful applicant will have a strong background in scale-up, process development, and manufacture of particle-based drug products. The candidate will focus on developing and implementing scalable and robust processes related to the formulation of lipid nanoparticles (LNP) with nucleic acids, as well as drug product development activities for lead pre-clinical programs. The successful candidate must be able to work in a fast paced and highly dynamic environment.

Responsibilities:
    • Design and execute experiments related to process improvements and optimization of lead Lipid Nanoparticle formulations
    • Explore, develop, and scale-up novel drug product processes
    • Explore process robustness of well characterized processes
    • Interact with internal and external groups to manufacture and supply formulations for in vivo studies
    • Develop analytical methods as needed to support and optimize formulation process development
    • Prepare technical reports and presentations as it relates to process optimization and scale-up
    • Write and review protocols and batch records for drug product processes
    • Develop intellectual property, publishing scientific papers and other tasks related to the company's scientific and business interests


Qualifications:
    • BS in Life Sciences, Chemical or Biological Engineering with 5+ years of industry experience, or Masters with 3+ years of industry experience
    • Experience designing, executing, and analyzing particle-based drug delivery systems
    • Demonstrated experience with process development and scale-up of complex drug products
    • Preferably has prior experience with LNP formulations with nucleic acids
    • Preferably has prior experience working with a frozen or lyophilized particle-based drug product.
    • Proficiency with a broad spectrum of analytical techniques applicable to nucleic acid drug delivery systems (i.e. particle size, fluorescent assays, HPLC/UPLC, etc).
    • Demonstrates creativity and problem-solving skills
    • Ability to work independently, as well as part of a team
    • Organized, detail-oriented, and a self-starter who continuously seeks to improve existing laboratory methods and processes.
    • Effective verbal and written communication skills.


#LI-KO1

What Intellia Stands For:

We push boundaries. We are focused on positively disrupting health care treatment of patients with genomic diseases. The values we live by and drivers we look for are:

- One is respect for individuals; our unique qualities and strengths; our own ways to understand, learn and improve. One is our single-minded determination to excel; to succeed together. One is you and us - trusting and counting on every single one of us.

- Explore because we seek new ways to tackle disease. Explore with unbounded minds...free from assumptions, open to ideas. Explore by staying curious, by pushing boundaries, overcoming obstacles. Explore means thinking of new ways.

- Disrupt by thinking courageously...and creating a better future. Disrupt by defying conformity; interrogating the status quo; questioning our momentum. Disrupt with challenging thoughts...with that breed of skepticism that shows you have better solutions.

- Deliver with your focus on the objective and your determination to complete the task. Deliver by advancing relentlessly and by maintaining high standards...even when nobody is watching. Deliver by staying accountable and pulling your weight. Deliver because patients are counting on us to make the promise reality. Get it done.

POSITION: Full-Time, Exempt

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Intellia's web-based application process is managed through Lever. Information submitted through application forms is collected by Lever and subject to Lever's privacy policy .

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert